Orthostatic Hypotension Drugs Market: by Diagnostic Test Type (ECG, Blood Tests, Stress Test and Other), Drug Type (Midodrine, Northera (droxidopa), Fludrocortisone, Caffeine and Others) and End user (Hospitals, ASCs and Clinics and Others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025

Published Date: 02-Dec-2019 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-5123 Status : Published

Global demand for Orthostatic Hypotension Drugs Market was valued at approximately USD 560.93 Million in 2018, and is expected to generate revenue of around USD 978.45 Million by end of 2025, growing at a CAGR of around 8.34% between 2018 and 2025.

Description

The report covers forecast and analysis for the Orthostatic Hypotension Drugs market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Orthostatic Hypotension Drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Orthostatic Hypotension Drugs market on a global level. In order to give the users of this report a comprehensive view on the Orthostatic Hypotension Drugs market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein Diagnostic Test Type, Drug Type, End user, and regional segments are benchmarked based on their market size, growth rate and general attractiveness.

According to the report, global demand for Orthostatic Hypotension Drugs Market was valued at approximately USD 560.93 Million in 2018, and is expected to generate revenue of around USD 978.45 Million by end of 2025, growing at a CAGR of around 8.34% between 2018 and 2025.

The prevalence of neurodegenerative diseases, cardiovascular diseases, and diabetes is increasing worldwide significantly, increasing the risk of Orthostatic hypotension. It is associated with a neurological disorder underlying autonomy. Dehydration is also a common condition in individuals that increases the risk of Orthostatic hypotension and causes nerve damage. This growth in the prevalence of chronic diseases associated with high risk of Orthostatic hypotension would result in the expansion of the global market for orthostatic hypotension drugs in the forecast period.

The study provides a decisive view on the Orthostatic Hypotension Drugs market by segmenting the market based on Diagnostic Test Type, Drug Type, End user and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on Diagnostic Test Type, the market is segmented into ECG, Blood Tests, Stress Test and Other. Based on the Drug Type segment, the market is bifurcated Midodrine, Northera (droxidopa), Fludrocortisone, Caffeine and Others. The midodrine group showed the largest market share of orthostatic hypotension drugs in 2018. Nonetheless, by the end of the forecast period, the Northera (droxidopa) segment will grow faster and emerge as the market leader. Based on the End user segment, the market is bifurcated into Hospitals, ASCs and Clinics and Others.

The geographical segmentation comprises the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. During the forecast period, North America will account for the largest market share of Orthostatic hypotension products. Factors such as high pharmaceutical expenditure per person, strong market presence of leading manufacturers, access to advanced healthcare, and increased awareness of Orthostatic hypotension contribute to the growth of this region's orthostatic hypotension drug market.

Orthostatic hypotension is a chronic debilitating disease that in several cases is difficult to treat. When treating orthostatic hypotension patients, single drug therapy may not be appropriate as orthostatic pressure varies with daytime circumstances. This has contributed to a growing emphasis on using combination therapy in orthostatic hypotension therapy. It is predicted that this innovation will have a positive impact on overall market growth. The prevalence of neurodegenerative diseases, cardiovascular diseases and diabetes is growing dramatically worldwide, raising the risk of Orthostatic hypotension. It is associated with an independent neurological disorder that underlies this. Dehydration is also a common condition in individuals which increases the risk of Orthostatic hypotension and causes nerve damage. This increase in the prevalence of chronic diseases associated with high risk of Orthostatic hypotension will result in the expansion of the global market for orthostatic hypotension drugs in the forecast period.

Key players within global Orthostatic Hypotension Drugs market include Amneal Pharmaceuticals Inc., H. Lundbeck AS, Mylan NV, Novartis AG and Pfizer Inc. amongst others.

The report segments global Orthostatic Hypotension Drugs market as follows:

Global Orthostatic Hypotension Drugs Market: Diagnostic Test Type Segment Analysis

  • ECG
  • Blood Tests
  • Stress Test
  • Other

Global Orthostatic Hypotension Drugs Market: Drug Type Segment Analysis

  • Midodrine
  • Northera (droxidopa)
  • Fludrocortisone
  • Caffeine
  • Others

Global Orthostatic Hypotension Drugs Market: End user Segment Analysis

  • Hospitals
  • ASCs and Clinics
  • Others

 Global Orthostatic Hypotension Drugs Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Orthostatic Hypotension Drugs Market, 2016 - 2025, (USD Million)
    • 2.2. Orthostatic Hypotension Drugs Market: Snapshot
  • Chapter 3. Global Orthostatic Hypotension Drugs Market - Industry Analysis
    • 3.1. Orthostatic Hypotension Drugs Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Increase in the prevalence of chronic diseases
    • 3.3. Restraints
      • 3.3.1. Side effects
    • 3.4. Opportunity
      • 3.4.1. Exploring emerging economies
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by Diagnostic Test Type Segment
      • 3.6.2. Market attractiveness analysis by Drug Type Segment
      • 3.6.3. Market attractiveness analysis by End user segment
      • 3.6.4. Market attractiveness analysis by regional segment
  • Chapter 4. Global Orthostatic Hypotension Drugs Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Orthostatic Hypotension Drugs market: company market share analysis, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Drug Type launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Orthostatic Hypotension Drugs Market - Diagnostic Test Type Segment Analysis
    • 5.1. Global Orthostatic Hypotension Drugs market overview: by Diagnostic Test Type
      • 5.1.1. Global Orthostatic Hypotension Drugs market revenue share, by Diagnostic Test Type, 2018 and 2025
    • 5.2. ECG
      • 5.2.1. Global Orthostatic Hypotension Drugs market by ECG, 2016-2025 (USD Million)
    • 5.3. Blood Tests
      • 5.3.1. Global Orthostatic Hypotension Drugs market by Blood Tests, 2016-2025 (USD Million)
    • 5.4. Stress Test
      • 5.4.1. Global Orthostatic Hypotension Drugs market by Stress Test, 2016-2025 (USD Million)
    • 5.5. Other
      • 5.5.1. Global Orthostatic Hypotension Drugs market by Other, 2016-2025 (USD Million)
  • Chapter 6. Global Orthostatic Hypotension Drugs Market - Drug Type Segment Analysis
    • 6.1. Global Orthostatic Hypotension Drugs market overview: by Drug Type
      • 6.1.1. Global Orthostatic Hypotension Drugs market revenue share, by Drug Type, 2018 and 2025
    • 6.2. Midodrine
      • 6.2.1. Global Orthostatic Hypotension Drugs market by Midodrine, 2016-2025 (USD Million)
    • 6.3. Northera (droxidopa)
      • 6.3.1. Global Orthostatic Hypotension Drugs market by Northera (droxidopa), 2016-2025 (USD Million)
    • 6.4. Fludrocortisone
      • 6.4.1. Global Orthostatic Hypotension Drugs market by Fludrocortisone, 2016-2025 (USD Million)
    • 6.5. Caffeine
      • 6.5.1. Global Orthostatic Hypotension Drugs market by Caffeine, 2016-2025 (USD Million)
    • 6.6. Others
      • 6.6.1. Global Orthostatic Hypotension Drugs market by Others, 2016-2025 (USD Million)
  • Chapter 7. Global Orthostatic Hypotension Drugs Market - End user Segment Analysis
    • 7.1. Global Orthostatic Hypotension Drugs market overview: by End user
      • 7.1.1. Global Orthostatic Hypotension Drugs market revenue share, by End user, 2018 and 2025
    • 7.2. Hospitals
      • 7.2.1. Global Orthostatic Hypotension Drugs market by Hospitals, 2016-2025 (USD Million)
    • 7.3. ASCs and Clinics
      • 7.3.1. Global Orthostatic Hypotension Drugs market by ASCs and Clinics, 2016-2025 (USD Million)
    • 7.4. Others
      • 7.4.1. Global Orthostatic Hypotension Drugs market by Others, 2016-2025 (USD Million)
  • Chapter 8. Global Orthostatic Hypotension Drugs Market - Regional Analysis
    • 8.1. Global Orthostatic Hypotension Drugs market overview: by region
      • 8.1.1. Global Orthostatic Hypotension Drugs market revenue share, by region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America Orthostatic Hypotension Drugs market, by country, 2016-2025 (USD Million)
      • 8.2.2. North America Orthostatic Hypotension Drugs market revenue, by Diagnostic Test Type, 2016-2025 (USD Million)
      • 8.2.3. North America Orthostatic Hypotension Drugs market revenue, by Drug Type, 2016-2025 (USD Million)
      • 8.2.4. North America Orthostatic Hypotension Drugs market revenue, by End user, 2016-2025 (USD Million)
      • 8.2.5. The U.S.
        • 8.2.5.1. U.S. Orthostatic Hypotension Drugs market revenue, by Diagnostic Test Type, 2016-2025 (USD Million)
        • 8.2.5.2. U.S. Orthostatic Hypotension Drugs market revenue, by Drug Type, 2016-2025 (USD Million)
        • 8.2.5.3. The U.S. Orthostatic Hypotension Drugs market revenue, by End user, 2016-2025 (USD Million)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America Orthostatic Hypotension Drugs market revenue, by Diagnostic Test Type, 2016-2025 (USD Million)
        • 8.2.6.2. Rest of North America Orthostatic Hypotension Drugs market revenue, by Drug Type, 2016-2025 (USD Million)
        • 8.2.6.3. Rest of North America Orthostatic Hypotension Drugs market revenue, by End user, 2016-2025 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Orthostatic Hypotension Drugs market, by country, 2016-2025 (USD Million)
      • 8.3.2. Europe Orthostatic Hypotension Drugs market revenue, by Diagnostic Test Type, 2016-2025 (USD Million)
      • 8.3.3. Europe Orthostatic Hypotension Drugs market revenue, by Drug Type, 2016-2025 (USD Million)
      • 8.3.4. Europe Orthostatic Hypotension Drugs market revenue, by End user, 2016-2025 (USD Million)
      • 8.3.5. UK
        • 8.3.5.1. UK Orthostatic Hypotension Drugs market revenue, by Diagnostic Test Type, 2016-2025 (USD Million)
        • 8.3.5.2. UK Orthostatic Hypotension Drugs market revenue, by Drug Type, 2016-2025 (USD Million)
        • 8.3.5.3. UK Orthostatic Hypotension Drugs market revenue, by End user, 2016-2025 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France Orthostatic Hypotension Drugs market revenue, by Diagnostic Test Type, 2016-2025 (USD Million)
        • 8.3.6.2. France Orthostatic Hypotension Drugs market revenue, by Drug Type, 2016-2025 (USD Million)
        • 8.3.6.3. France Orthostatic Hypotension Drugs market revenue, by End user, 2016-2025 (USD Million)
      • 8.3.7. Germany
        • 8.3.7.1. Germany Orthostatic Hypotension Drugs market revenue, by Diagnostic Test Type, 2016-2025 (USD Million)
        • 8.3.7.2. Germany Orthostatic Hypotension Drugs market revenue, by Drug Type, 2016-2025 (USD Million)
        • 8.3.7.3. Germany Orthostatic Hypotension Drugs market revenue, by End user, 2016-2025 (USD Million)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of Europe Orthostatic Hypotension Drugs market revenue, by Diagnostic Test Type, 2016-2025 (USD Million)
        • 8.3.8.2. Rest of Europe Orthostatic Hypotension Drugs market revenue, by Drug Type, 2016-2025 (USD Million)
        • 8.3.8.3. Rest of Europe Orthostatic Hypotension Drugs market revenue, by End user, 2016-2025 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Orthostatic Hypotension Drugs market, by country, 2016-2025 (USD Million)
      • 8.4.2. Asia Pacific Orthostatic Hypotension Drugs market revenue, by Diagnostic Test Type, 2016-2025 (USD Million)
      • 8.4.3. Asia Pacific Orthostatic Hypotension Drugs market revenue, by Drug Type, 2016-2025 (USD Million)
      • 8.4.4. Asia Pacific Orthostatic Hypotension Drugs market revenue, by End user, 2016-2025 (USD Million)
      • 8.4.5. China
        • 8.4.5.1. China Orthostatic Hypotension Drugs market revenue, by Diagnostic Test Type, 2016-2025 (USD Million)
        • 8.4.5.2. China Orthostatic Hypotension Drugs market revenue, by Drug Type, 2016-2025 (USD Million)
        • 8.4.5.3. China Orthostatic Hypotension Drugs market revenue, by End user, 2016-2025 (USD Million)
      • 8.4.6. France
        • 8.4.6.1. Japan Orthostatic Hypotension Drugs market revenue, by Diagnostic Test Type, 2016-2025 (USD Million)
        • 8.4.6.2. Japan Orthostatic Hypotension Drugs market revenue, by Drug Type, 2016-2025 (USD Million)
        • 8.4.6.3. Japan Orthostatic Hypotension Drugs market revenue, by End user, 2016-2025 (USD Million)
      • 8.4.7. India
        • 8.4.7.1. India Orthostatic Hypotension Drugs market revenue, by Diagnostic Test Type, 2016-2025 (USD Million)
        • 8.4.7.2. India Orthostatic Hypotension Drugs market revenue, by Drug Type, 2016-2025 (USD Million)
        • 8.4.7.3. India Orthostatic Hypotension Drugs market revenue, by End user, 2016-2025 (USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific Orthostatic Hypotension Drugs market revenue, by Diagnostic Test Type, 2016-2025 (USD Million)
        • 8.4.8.2. Rest of Asia Pacific Orthostatic Hypotension Drugs market revenue, by Drug Type, 2016-2025 (USD Million)
        • 8.4.8.3. Rest of Asia Pacific Orthostatic Hypotension Drugs market revenue, by End user, 2016-2025 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Orthostatic Hypotension Drugs market, by country, 2016-2025 (USD Million)
      • 8.5.2. Latin America Orthostatic Hypotension Drugs market revenue, by Diagnostic Test Type, 2016-2025 (USD Million)
      • 8.5.3. Latin America Orthostatic Hypotension Drugs market revenue, by Drug Type, 2016-2025 (USD Million)
      • 8.5.4. Latin America Orthostatic Hypotension Drugs market revenue, by End user, 2016-2025 (USD Million)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil Orthostatic Hypotension Drugs market revenue, by Diagnostic Test Type, 2016-2025 (USD Million)
        • 8.5.5.2. Brazil Orthostatic Hypotension Drugs market revenue, by Drug Type, 2016-2025 (USD Million)
        • 8.5.5.3. Brazil Orthostatic Hypotension Drugs market revenue, by End user, 2016-2025 (USD Million)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America Orthostatic Hypotension Drugs market revenue, by Diagnostic Test Type, 2016-2025 (USD Million)
        • 8.5.6.2. Rest of Latin America Orthostatic Hypotension Drugs market revenue, by Drug Type, 2016-2025 (USD Million)
        • 8.5.6.3. Rest of Latin America Orthostatic Hypotension Drugs market revenue, by End user, 2016-2025 (USD Million)
    • 8.6. Middle East & Africa
      • 8.6.1. Middle East and Africa Orthostatic Hypotension Drugs market, by country, 2016-2025 (USD Million)
      • 8.6.2. Middle East and Africa Orthostatic Hypotension Drugs market revenue, by Diagnostic Test Type, 2016-2025 (USD Million)
      • 8.6.3. Middle East and Africa Orthostatic Hypotension Drugs market revenue, by Drug Type, 2016-2025 (USD Million)
      • 8.6.4. Middle East and Africa Orthostatic Hypotension Drugs market revenue, by End user, 2016-2025 (USD Million) 
  • Chapter 10. Company Profiles
    • 10.1. Agennix AG
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Drug Type Portfolio
      • 10.1.4. Business Strategy
      • 10.1.5. Recent Developments
    • 10.2. AstraZeneca
      • 10.2.1. Overview
      • 10.2.2. Financials
      • 10.2.3. Drug Type Portfolio
      • 10.2.4. Business Strategy
      • 10.2.5. Recent Developments
    • 10.3. Eli Lily
      • 10.3.1. Overview
      • 10.3.2. Financials
      • 10.3.3. Drug Type Portfolio
      • 10.3.4. Business Strategy
      • 10.3.5. Recent Developments
    • 10.4. GlaxoSmithKline
      • 10.4.1. Overview
      • 10.4.2. Financials
      • 10.4.3. Drug Type Portfolio
      • 10.4.4. Business Strategy
      • 10.4.5. Recent Developments
    • 10.5. Merck & Co.
      • 10.5.1. Overview
      • 10.5.2. Financials
      • 10.5.3. Drug Type Portfolio
      • 10.5.4. Business Strategy
      • 10.5.5. Recent Developments
    • 10.6. Novartis AG
      • 10.6.1. Overview
      • 10.6.2. Financials
      • 10.6.3. Drug Type Portfolio
      • 10.6.4. Business Strategy
      • 10.6.5. Recent Developments
    • 10.7. Pfizer
      • 10.7.1. Overview
      • 10.7.2. Financials
      • 10.7.3. Drug Type Portfolio
      • 10.7.4. Business Strategy
      • 10.7.5. Recent Developments
    • 10.8. Roche
      • 10.8.1. Overview
      • 10.8.2. Financials
      • 10.8.3. Drug Type Portfolio
      • 10.8.4. Business Strategy
      • 10.8.5. Recent Developments

Methodology

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social